We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Eli Lilly’s lower-cost generic of its blockbuster insulin drug Humalog (insulin lispro) hit pharmacies on Wednesday following months of heat from both Congress and the White House over high insulin drug prices. Read More
The jury awarded Guo $1.8 million in damages, but it also found that she had violated company policy in her handling of the dispute and awarded Novartis damages. Read More
Novartis is hinting that it will appeal a New Jersey jury’s verdict awarding $1.5 million to a former executive who alleged that the company created a bogus drug study to disguise kickbacks to a leading drug distributor. Read More
The lawsuit claims Ranbaxy’s lawyers and Parexel, a consulting firm they retained, entered into an agreement “structured to shield Parexel’s audit work from any FDA scrutiny.” Read More
A group of indirect purchasers filed a RICO lawsuit against Indian drugmaker Ranbaxy, claiming the company cost them millions of dollars through a criminal enterprise. Read More
According to the complaint, the board pressed sales staff to specifically pressure doctors it identified as key opinion leaders to use their influence to increase prescribing. Read More
Newly unredacted portions of Massachusetts’ lawsuit against Purdue Pharma reveal details of the aggressive sales tactics the lawsuit claims the Oxycontin manufacturer used to increase sales of its opioid products. Read More
As the new Congress looks for ways to address high drug prices, two prominent lawmakers asked Eli Lilly, Novo Nordisk and Sanofi to explain the soaring prices of their insulin products. Read More